Long-term cardiovascular effects of anabolic steroids

Lancet

Volumn 352, Issue 9121, 1998, Pages 33-

  Madea, Burkhard ^a   Grellner, Wolfgang ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; HYDROCORTISONE; LIPID; MESTEROLONE; METANDIENONE; METHYLTESTOSTERONE; NANDROLONE DECANOATE; OXANDROLONE; TAMOXIFEN CITRATE; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADULT; ARTICLE; AUTOPSY; BODY BUILDING; CARDIOVASCULAR EFFECT; CASE REPORT; DEPRESSION; DOSE RESPONSE; DRUG ABUSE; ECHOCARDIOGRAPHY; FRACTURE; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGONADISM; LIPID METABOLISM; LONG TERM CARE; MALE; MOOD; MUSCLE INJURY; OBESITY; PRIORITY JOURNAL; SYMPTOM; TESTOSTERONE BLOOD LEVEL;

EID: 0032482657     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79512-X     Document Type: Article

References (2)

1. 1 Korkia P. Anabolic steroid use. Lancet 1993; 341: 1407.
2. 2 McNutt RA, Ferenchick GS, Kirlin PC, Hamlin HJ. Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 1988; 62: 164.